Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
Monday on WRAL at 6 : Gunfire and home break-ins. WRAL Investigates how Durham violence is spilling into Wake County neighborhoods.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
ZyVersa Therapeutics, Inc. - Common Stock
(NQ:
ZVSA
)
1.400
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ZyVersa Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Why iMedia Brands Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
April 12, 2023
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) jumped 119.6% to $1.96 in pre-market trading. HeartCore forged an agreement with rYojbaba Inc for its tenth Go IPO consulting service win.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 12, 2023
Pre-market stock movers are a hot topic on Wednesday as we dive into all of the latest news affecting markets this morning.
Via
InvestorPlace
ZyVersa Therapeutics' CEO, Stephen C. Glover, to Present at Planet MicroCap Showcase
April 11, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
Why Is ZyVersa Therapeutics (ZVSA) Stock Up 35% Today?
March 23, 2023
ZyVersa Therapeutics (ZVSA) stock is taking off on Thursday morning without any recent news from the biopharmaceutical company.
Via
InvestorPlace
ZyVersa Therapeutics Announces Article Published in Brain Pathology Addressing Inflammasome Signaling Proteins in Alzheimer’s Disease
April 10, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
ZyVersa Therapeutics Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results
April 03, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
March 23, 2023
Via
Benzinga
Why Is Cidara Therapeutics (CDTX) Stock Down 12% Today?
March 23, 2023
Cidara Therapeutics (CDTX) stock is falling on Thursday despite the immunotherapy company getting positive news from the FDA.
Via
InvestorPlace
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 23, 2023
Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 23, 2023
Via
Benzinga
Why Is Coinbase (COIN) Stock Down 15% Today?
March 23, 2023
Coinbase Global (COIN) stock is falling on Thursday after the SEC threatened to investigate the crypto exchange's business.
Via
InvestorPlace
Why Is Advent Technologies (ADN) Stock Up 32% Today?
March 23, 2023
Advent Technologies (ADN) stock is climbing higher on Thursday following news of a fuel cell agreement with Hyundai (HYMTF).
Via
InvestorPlace
Why Agile Therapeutics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
March 23, 2023
Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) shares rose 82.8% to $2.98 in pre-market trading. ZyVersa Therapeutics recently reported new employment inducement grants under Nasdaq Listing Rule...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 23, 2023
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning!
Via
InvestorPlace
ZyVersa Therapeutics Reports New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 13, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
ZyVersa Therapeutics Adds Dr. Richard J. Glassock to Its Renal Scientific Advisory Board to Support Clinical Advancement of Renal Cholesterol Efflux Mediator™ VAR 200
March 07, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
ZyVersa Therapeutics to Participate in a Fireside Chat at Oppenheimer Healthcare Conference
March 01, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
ZyVersa Therapeutics to Participate in a Fireside Chat at Roth Annual Conference
February 27, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
ZyVersa Therapeutics Announces New Publication in Translational Research Showing IC 100 Reduces Inflammasome Activation in Mouse Model for Alzheimer’s Disease Following Traumatic Brain Injury
February 23, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
February 17, 2023
We're starting off the final trading day of the week with a look at the biggest pre-market stock movers worth watching on Friday!
Via
InvestorPlace
Why Axcella Health Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket
February 16, 2023
Gainers Axcella Health Inc. (NASDAQ: AXLA) shares rose 54.1% to $0.9290 in pre-market trading after the company announced FDA clearance of its IND application to initiate a phase 2b/3 trial in the U.S....
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 16, 2023
It's time to start the day with an overview of the biggest pre-market stock movers worth keeping an eye on Thursday morning!
Via
InvestorPlace
Genius Group (GNS) Stock Skyrockets 39% on NFT Plans
February 02, 2023
Genius Group (GNS) stock is taking off on Thursday after the company revealed plans to offer NFTs coupons with its shares.
Via
InvestorPlace
Why Is OncoSec Medical (ONCS) Stock Down 25% Today?
February 02, 2023
OncoSec Medical (ONCS) stock is falling on Thursday after the company revealed some details of a planned stock offering.
Via
InvestorPlace
Why Is TeraWulf (WULF) Stock Down 34% Today?
February 02, 2023
TeraWulf (WULF) stock is taking a beating on Thursday after the crypto mining company revealed plans for a public stock offering.
Via
InvestorPlace
Why Is ZyVersa Therapeutics (ZVSA) Stock Up 94% Today?
February 02, 2023
ZyVersa Therapeutics (ZVSA) stock is flying higher on Thursday as investors react to a preliminary prospectus for a stock offering.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 02, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!
Via
InvestorPlace
Why Meta Platforms Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
February 02, 2023
Gainers Tenax Therapeutics, Inc (NASDAQ: TENX) shares rose 172.8% to $4.61 in pre-market trading. Tenax was granted a Notice of Allowance for U.S. Patent application for use of IV levosimendan in...
Via
Benzinga
ZyVersa Therapeutics Reports Inducement Grant to Newly Appointed Chief Medical Officer Under Nasdaq Listing Rule 5635(c)(4)
January 27, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 26, 2023
We're starting off the day with an overview of the biggest pre-market stock movers that traders need to watch on Thursday!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.